Inhibition of Human T Lymphocyte Proliferation and Cytokine Production by 1,25-Dihydroxyvitamin D₃. Differential Effects on Cd45Ra+ and Cd45R0+ Cells

References

• Reichel H, Koeffler P, Norman A W. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 980–991
   PubMed Web of Science ®Google Scholar
• Provvedini D M, Tsoukas C D, Deftos L J, Manolagas S C. 1.25–dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221: 1181–1183
   PubMed Web of Science ®Google Scholar
• Rigby W F. The immunobiology of vitamin D. Immunol Today 1988; 9: 54–58
   PubMedGoogle Scholar
• Manolagas S C, Hustrnyer F G, Yu X-P. Immunomodulating properties of 1,25-dihydroxyvitamin D3. Kidney Int 1990; 38: S9–S16
   Web of Science ®Google Scholar
• Rigby W F, Stacy T, Fanger M W. Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984; 74: 1451–1455
   PubMed Web of Science ®Google Scholar
• Rigby W F, Noelle R J, Krause K, Fanger M W. The effects of 1,25-dihydroxyvitamin D, on human T lymphocyte activation and proliferation: a cell cycle analysis. J Immunol 1985; 135: 2279–2286
   PubMed Web of Science ®Google Scholar
• Müller K, Svenson M, Bendtzen K. lα-25-dihydroxyvitamin D3 and a novel vitamin D analogue MC 903 are potent inhibitors of human interleukin I in vitro. Immunol Lett 1988; 17: 361–366
   PubMed Web of Science ®Google Scholar
• Müller K, Diamant M, Bendtzen K. Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3. Immunol Lett 1991; 28: 115–120
   PubMed Web of Science ®Google Scholar
• Lemire J M, Adams J S, Sakai R, Jordan S C. lα.25-dihydroxy-vitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657–661
   PubMed Web of Science ®Google Scholar
• Iho S, Takahashi T, Kura F, Sugiyarna H, Hoshino T. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol 1986; 136: 4427–4431
   PubMed Web of Science ®Google Scholar
• Müller K, Heilmann C, Poulsen L K, Barington T, Bendtzen K. The role of monocytes and T cells in 1,25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro. Immunopharmacol 1991; 21: 121–128
   PubMedGoogle Scholar
• Tsoukas C D, Provvedini D M, Manolagas S C. 1,25-dihydroxyvitamin D2: a novel immunoregulatory hormone. Science, 224: 1438–1440
   PubMed Web of Science ®Google Scholar
• Reichel H, Koeffler H P, Tobler A, Norman A W. 1 alpha. 25-dihydroxyvitamin D, inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1987; 84: 3385–3389
   PubMed Web of Science ®Google Scholar
• Barbour G L, Coburn J W, Slatopolsky E, Norman A W, Horst R L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 1981; 305: 440–443
   PubMed Web of Science ®Google Scholar
• Adarns J S, Gacad M A. Characterization of 1α-hydroxylation of vitamin D3 sterols by cultured aveolar macrophages from patients with sarcoidosis. J Exp Med 1985; 161: 755–765
   PubMed Web of Science ®Google Scholar
• Hayes M E, Denton J, Freemont A J, Mawer E B. Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3. by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis 1989; 48: 723–729
   PubMed Web of Science ®Google Scholar
• Streuli M, Hall L R, Saga Y, Schlossman S F, Saito H. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J Exp Med 1987; 166: 1548–1566
   PubMed Web of Science ®Google Scholar
• Sanders M E, Makgoba M W, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol Today 1988; 9: 195–199
   PubMedGoogle Scholar
• Morimoto C, Letvin N L, Boyd A W, Hagan M, Brown H M, Kornacki M M, et al. The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985; 134: 3762–3769
   PubMed Web of Science ®Google Scholar
• Lasky H P, Bauer K, Pope R M. Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint. Arthritis Rheum 1988; 31: 52–59
   PubMed Web of Science ®Google Scholar
• Koch A E, Robinson P G, Radosevich J A, Pope R M. Distribution of CD45RA and CD45RO T-lymphocyte subsets in rheumatoid arthritis synovial tissue. J Clin Immunol 1990; 10: 192–199
   PubMed Web of Science ®Google Scholar
• Chofflon M, González V, Weiner H L, Hafler D A. Inflammatory cerebrospinal fluid T cells have activation requirements characteristic of CD4+ CD45RA- T cells. Eur J Immunol 1989; 19: 1791–1795
   PubMed Web of Science ®Google Scholar
• Svenson M, Bendtzen K. Human urine deoxyribonuclease increases endogenous thymidine in the mouse thymocyte interleukin I assay: An artifkal interleukin-I inhibitor. Cytokine 1989; 1: 52–55
   PubMedGoogle Scholar
• Fomsgaard A, Worsaae H, Bendtzen K. Detection of tumour necrosis factor from lipopolysaccharide-stimulated human mononuclear cells by enzyme-linked immunosorbent assay and cytotoxicity bioassay. Scand J Immunol 1988; 27: 143–147
   PubMed Web of Science ®Google Scholar
• Aarden L A, de Groot E R, Schaap O L, Lansdorp P M. Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987; 17: 1411–1416
   PubMed Web of Science ®Google Scholar
• Gillis S, Ferm M M, Ou W, Smith K A. T cell growth factor; parameters of production and a quantitative rnicroassay for activity. J Immunol 1978; 120: 2027–2031
   PubMed Web of Science ®Google Scholar
• Saxon A, Feldhaus J, Robins R A. Single step separation of human T and B cells using AET treated SRBC rosettes. J Immunol Methods 1976; 12: 285–288
   PubMed Web of Science ®Google Scholar
• Hansen M B, Svenson M, Bendtzen K. Human anti-interleukin lα antibodies. Immunol Lett 1991; 30: 133–140
   PubMed Web of Science ®Google Scholar
• Lemire J M, Adams J S, Kermani-Arab V, Bakke A C, Sakai R, Jordan S C. 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 1985; 134: 3032–3035
   PubMed Web of Science ®Google Scholar
• Provvedini D M, Manolagas S C. 1,25-Dihydroxyvitamin D3 receptor distribution and effects in subpopulations of normal human T lymphocytes. J Clin Endocrinol Metab 1989; 68: 774–779
   PubMed Web of Science ®Google Scholar
• Jordan S C, Lemire J M, Sakai R S, Toyoda M, Adam J S. Exogenous interleukin-2 does not reverse the immunoinhibitory effects of 1.25-dihydroxyvitamin D, on human peripheral blood lymphocyte immunoglobulin production. Mol Immunol 1990; 27: 95–100
   PubMed Web of Science ®Google Scholar
• Rigby W F, Yirinec B, Oldershaw R L, Fanger M W. Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations. Eur J Immunol 1987; 17: 563–566
   PubMed Web of Science ®Google Scholar
• Iho S, Iwamoto K, Fura F, Okuno Y, Takahashi T, Hoshino T. Mechanism in 1,25(OH)2D3-induced suppression of helper/ suppressor function of CD4/CD8 cells to immunoglobulin production in B cells. Cell Immunol 1990; 127: 12–25
   PubMed Web of Science ®Google Scholar
• Clement L T, Yamashita N, Martin A M. The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 1988; 141: 1464–1470
   PubMed Web of Science ®Google Scholar
• Kristensson K, Dohlsten M, Fischer H, Ericsson P O, Hedlund G, Sjögren H O, et al. Phenotypical and functional differentiation of CD4+ CD45RA+ human T cells following polyclonal activation. Scand J Immunol 1990; 32: 243–253
   PubMed Web of Science ®Google Scholar
• Rigby W FC, Denome S, Fanger M W. Regulation of lympho-kine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D. Specific inhibition at the level of messenger RNA. J Clin Invest 1986; 79: 1659–1664
   Web of Science ®Google Scholar
• Rigby W F, Hamilton B J, Waugh M G. 1,25-dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding. Cell Immunol 1990; 125: 396–414
   PubMed Web of Science ®Google Scholar